Form 8-K - Current report:
SEC Accession No. 0001193125-24-190764
Filing Date
2024-08-01
Accepted
2024-08-01 08:36:59
Documents
18
Period of Report
2024-08-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d814318d8k.htm   iXBRL 8-K 47991
2 EX-3.1 d814318dex31.htm EX-3.1 8235
3 EX-3.2 d814318dex32.htm EX-3.2 82423
4 EX-4.1 d814318dex41.htm EX-4.1 21742
5 EX-99.1 d814318dex991.htm EX-99.1 19406
9 GRAPHIC g814318g0801015501013.jpg GRAPHIC 1881
  Complete submission text file 0001193125-24-190764.txt   353168

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cere-20240801.xsd EX-101.SCH 2850
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cere-20240801_lab.xml EX-101.LAB 18739
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cere-20240801_pre.xml EX-101.PRE 11707
20 EXTRACTED XBRL INSTANCE DOCUMENT d814318d8k_htm.xml XML 3857
Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Filer) CIK: 0001805387 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39311 | Film No.: 241164574
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)